Long-term efficacy of agomelatine, a novel antidepressant, in the prevention of relapse in out-patients with major depressive disorder

被引：9
|
作者：
Goodwin, G. M. [1 ]
Rouillon, F. [2 ]
Emsley, R. [3 ]
机构：
[1] Univ Oxford, Dept Psychiat, Oxford, England
[2] Ctr Hosp St Anne, Paris, France
[3] Univ Stellenbosch, Dept Psychiat, Cape Town, South Africa
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2007年 / 17卷
关键词：
D O I：
10.1016/S0924-977X(07)70529-1
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S361 / S362
页数：2
相关论文
共 50 条
  • [1] Long-term treatment with agomelatine: prevention of relapse in patients with Major Depressive Disorder over 10 months
    Goodwin, G. M.
    Rouillon, F.
    Emsley, R.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2008, 18 : S338 - S339
  • [2] EFFICACY OF THE ANTIDEPRESSANT AGOMELATINE FOR THE ANXIETY SYMPTOMS OF DEPRESSION IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER
    Stein, D. J.
    Castle, D. J.
    Kennedy, S. H.
    [J]. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2012, 46 : 31 - 32
  • [3] EFFICACY OF AGOMELATINE IN ELDERLY PATIENTS WITH MAJOR DEPRESSIVE DISORDER
    Flynn, Patrick
    Heun, Reinhaud
    Corral, Ricardo
    Ahokas, Antti
    Nicolini, Humberto
    Teixeria, Joao
    Dehelean, Pompilia
    [J]. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2013, 47 (S1): : 46 - 47
  • [4] Sustained efficacy and safety of agomelatine versus placebo over 24 weeks in elderly out-patients suffering from major depressive disorder
    Heun, R.
    Corral, R.
    Ahokas, A.
    Nicolini, H.
    Teixeira, J. M.
    Dehelean, P.
    Picarel-Blanchot, F.
    De Bodinat, C.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 : S403 - S404
  • [5] LONG-TERM TREATMENT WITH AGOMELATINE: PREVENTION OF RELAPSE IN PATIENTS WITH GENERALISED ANXIETY DISORDER OVER 6 MONTHS
    Stein, D.
    Ahokas, A.
    Allgulander, C.
    Soegaard, J.
    Bitter, I.
    Lehtmets, A.
    Wahlstedt, K.
    Van Amerigen, M.
    [J]. EUROPEAN PSYCHIATRY, 2011, 26
  • [6] Maintenance of vortioxetine efficacy with long-term treatment of patients with major depressive disorder
    Vieta, E.
    Loft, H.
    Florea, I.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 : S458 - S459
  • [7] Efficacy of agomelatine for anxiety symptoms in adult patients with major depressive disorder
    Stein, D.
    Chimits, D.
    Picarel-Blanchot, F.
    Khoo, J. P.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2020, 40 : S59 - S60
  • [8] The Long-Term Effects of Mindfulness-Based Cognitive Therapy as a Relapse Prevention Treatment for Major Depressive Disorder
    Mathew, Kate L.
    Whitford, Hayley S.
    Kenny, Maura A.
    Denson, Linley A.
    [J]. BEHAVIOURAL AND COGNITIVE PSYCHOTHERAPY, 2010, 38 (05) : 561 - 576
  • [9] Antidepressant efficacy of agomelatine in major depressive disorder: meta-analysis of three pivotal studies
    Montgomery, S. A.
    Olie, J. P.
    Kennedy, S. H.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2006, 16 : S321 - S322
  • [10] Long-term management of major depressive disorder: Are differences among antidepressant treatments meaningful?
    Shelton, CI
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2004, 65 : 29 - 33
12345